The Oncologist newsletter appeared in my in-box this morning. As well as a lot of peripheral interest there were a few articles about haematological malignancies including:
Hematologic Malignancies
|
Yushi Li, Huanhuan Sun, Yan Yan, Tiantian Sun, Shuncong Wang, Haiqing Ma
This
article examines interpatient differences in advanced Hodgkin lymphoma
incidence and long-term survival using data from the SEER database.
Socioeconomic status and racial heterogeneities in the U.S. health care
system have drawn increasing attention from oncologists and
epidemiologists; therefore whether a patient’s demographic
characteristics and socioeconomic status.
Haige Ye, Aakash Desai, Dongfeng Zeng, Jorge Romaguera, Michael L. Wang
This
article presents frontline treatments for elderly patients with mantle
cell lymphoma who need treatment in three different fitness levels (fit,
unfit, or compromised and frail).
Xiao-Dong
Mo, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Chen-Hua Yan, Huan Chen,
Yu-Hong Chen, Ya-Zhen Qin, Kai-Yan Liu, Xiao-Jun Huang
RUNX1-RUNX1T1
transcript levels are markers for predicting relapse in patients with
t(8;21) acute myeloid leukemia (AML). This article reports the efficacy
of minimal residual disease-directed interferon-alpha (IFN-α) treatment
in patients with t(8;21) AML who were positive for minimal residual
disease after allogeneic hematopoietic stem cell transplantation.
No comments:
Post a Comment